Publication | Open Access

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

InflammationAnti-inflammatoryInternational RegistryImmunologyGastroenterologyTnf AntagonistsInflammatory BowelMedicineInflammatory DiseaseInflammatory ArthritisCovid-19